Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-comparative, Single Dose-Escalation Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B

NCT06120582 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT06120582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06120582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-comparative, Single Dose-Escalation Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B
Lead sponsor
Biocad
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 2, 2023
Completion date
November 30, 2029
Enrollment
28 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b